Covered recipient · General Payments record
GILLIAN M GODDARD
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$24,433.51
- Reported across 1,290 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,911.64 | 152 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $461.10 | 30 |
| Novo Nordisk AS | $396.92 | 21 |
| SANOFI-AVENTIS U.S. LLC | $272.18 | 9 |
| Astellas Pharma US Inc | $265.17 | 10 |
| ABBVIE INC. | $207.81 | 21 |
| Amgen Inc. | $148.53 | 9 |
| Bayer HealthCare Pharmaceuticals Inc. | $131.30 | 5 |
| IBSA Pharma Inc. | $108.13 | 5 |
| Antares Pharma, Inc. | $101.47 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.97 | 3 |
| Amneal Pharmaceuticals LLC | $91.38 | 4 |
| PFIZER INC. | $84.37 | 4 |
| Kyowa Kirin, Inc. | $81.29 | 4 |
| Xeris Pharmaceuticals, Inc. | $64.46 | 3 |
| INTRA-SANA LABORATORIES | $53.23 | 3 |
| DEXCOM, INC. | $46.55 | 2 |
| Verity Pharmaceuticals Inc. | $36.00 | 2 |
| Acella Pharmaceuticals, LLC | $34.49 | 2 |
| Insulet Corporation | $30.38 | 1 |
| CHIESI USA, INC. | $29.73 | 1 |
| MannKind Corporation | $28.96 | 2 |
| VIVUS LLC | $24.13 | 1 |
| Averitas Pharma Inc. | $23.05 | 1 |
| Alexion Pharmaceuticals, Inc. | $23.01 | 1 |
| Medtronic, Inc. | $22.22 | 1 |
| Avvisto Therapeutics, LLC | $18.99 | 1 |
| TOLMAR, INC. | $16.62 | 1 |
| Currax Pharmaceuticals LLC | $16.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (152)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.